Can tech for good be as profitable as plain old tech?
Duke U, Mayo Clinic, et al collab for innovative AI
Broad Institute, Intel, Google Advance Biomedical Research
Microsoft’s next moves: Biz dev and strategy leader Christopher Young is focusing on these key areas
Drug discovery platform Exscientia sets terms for $275 million US IPO
Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design
Analysts compile top European biotech news of 2021
Accenture’s Julie Sweet: A.I. can transform companies, creating ‘responsibility and possibility’ for CEOs
AI drug discovery platform raises Series B funding
Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement
ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding
ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie
